By Crystal A. Frost, PhD On November 6-7, the California Board of Pharmacy (BOP) is expected to vote to restrict access to safe and critical Category 1 substances like glutathione, NAD+ and methylcobalamin (the active and most bioavailable form of vitamin B12). These treatments... Read More »